Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy

Exclusion criteria

• . Prior surgical procedure for hyperhidrosis.
• . Iontophoresis for the palms 4 weeks prior to randomization.
• . Treatment with botulinum toxin (e.g., Botox) for hand hyperhidrosis 6 months prior to randomization.
• . Known allergy to any of the components in the investigational product, as well as to atropine or its derivatives, e.g., ipratropium or oxitropium.
• . Subjects who are actively participating in an experimental therapy study or who received experimental therapy 30 days or 5 half-lives (whichever is longer) prior to randomization.
• . Subjects who have had a change in a regimen of psychotherapeutic medication (change in drug, dose, frequency) or who have started a psychoactive medication prior to two months of randomization.
• . Treatment with medications having systemic anticholinergic activity, centrally acting alpha-2 adrenergic agonists (e.g., clonidine, guanabenz, methyl dopa), or beta-blockers 4 weeks prior to randomization.
• . Treatment with Spiriva or similar, or any systemic treatment with an anticholinergic medication such as, but not limited to atropine belladonna, scopolamine, aclidinium, hyoscyamine, oxybutynin or glycopyrronium within 4 weeks prior to randomization.